Comparison between ideaForge Technology IPO and Mankind Pharma IPO.
ideaForge Technology IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Mankind Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of ideaForge Technology IPO is up to ₹567.24 Cr whereas the issue size of the Mankind Pharma IPO is up to ₹4,326.36 Cr. The final issue price of ideaForge Technology IPO is ₹672.00 per share and of Mankind Pharma IPO is ₹1,080.00 per share.
| ideaForge Technology IPO | Mankind Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ₹638.00 per share | ₹1,026.00 per share |
| Issue Price (Upper) | ₹672.00 per share | ₹1,080.00 per share |
| Issue Price (Final) | ₹672.00 per share | ₹1,080.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹32.00 per share | |
| Market Lot Size | 22 shares | 13 shares |
| Fresh Issue Size | 35,72,052 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹240.02 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 48,69,712 shares | 4,00,58,844 shares |
| OFS Issue Size (Amount) | up to ₹327.22 Cr | up to ₹4,326.36 Cr |
| Issue Size Total | 84,41,764 shares | 4,00,58,844 shares |
| Issue Size Total (Amount) | up to ₹567.24 Cr | up to ₹4,326.36 Cr |
ideaForge Technology IPO opens on Jun 26, 2023, while Mankind Pharma IPO opens on Apr 25, 2023. The closing date of ideaForge Technology IPO and Mankind Pharma IPO is Jun 30, 2023, and Apr 27, 2023, respectively.
| ideaForge Technology IPO | Mankind Pharma IPO | |
|---|---|---|
| Anchor Bid Date | Jun 23, 2023 | Apr 24, 2023 |
| Issue Open | Jun 26, 2023 | Apr 25, 2023 |
| Issue Close | Jun 30, 2023 | Apr 27, 2023 |
| Basis Of Allotment (Tentative) | Jul 05, 2023 | May 03, 2023 |
| Initiation of Refunds (Tentative) | Jul 06, 2023 | May 04, 2023 |
| Credit of Share (Tentative) | Jul 07, 2023 | May 05, 2023 |
| Listing date (Tentative) | Jul 07, 2023 | May 09, 2023 |
| Anchor Lockin End date 1 | Aug 04, 2023 | Jun 02, 2023 |
| Anchor Lockin End date 2 | Oct 03, 2023 | Aug 01, 2023 |
ideaForge Technology IPO P/E ratio is 87.5, as compared to Mankind Pharma IPO P/E ratio of 32.5.
| ideaForge Technology IPO | Mankind Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 33.37 | 79.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 30.19 | 76.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 87.5 | 32.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹2800.20 Cr. | ₹43263.60 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 13.11% | 27.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 12.51% | 26.10% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.27 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.12 | ₹33.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 9.85% | 27.70% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the ideaForge Technology IPO Retail Individual Investors (RII) are offered 8,42,865 shares while in Mankind Pharma IPO retail investors are offered 8,42,865 shares. Qualified Institutional Buyers (QIB) are offered 25,28,596 shares in ideaForge Technology IPO and 80,11,769 shares in Mankind Pharma IPO.
| ideaForge Technology IPO | Mankind Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 37,92,894 shares | 1,20,17,652 shares |
| Market Maker Reservation | ||
| QIB | 25,28,596 shares | 80,11,769 shares |
| NII | 12,64,297 shares | 60,08,827 shares |
| RII | 8,42,865 shares | 1,40,20,596 shares |
| Employee | 13,112 shares | |
| Others | ||
| Total | 84,41,764 shares | 4,00,58,844 shares |
ideaForge Technology IPO subscribed 106.06x in total, whereas Mankind Pharma IPO subscribed 15.32x.
| ideaForge Technology IPO | Mankind Pharma IPO | |
|---|---|---|
| QIB (times) | 125.81x | 49.16x |
| NII (times) | 80.58x | 3.80x |
| Big NII (times) | 81.99x | 4.99x |
| Small NII (times) | 77.77x | 1.41x |
| RII (times) | 85.20x | 0.92x |
| Employee (times) | 96.65x | |
| Other (times) | ||
| Total (times) | 106.06x | 15.32x |
